Purple Biotech Ltd PPBT
1.18 USD -0.05 -4.07%
As of Nov 3, 2:18 PM ET
- YTD
- -82.07%
- 1 year
- -86.30%
- Open
- 1.25
- Prev close
- 1.23
- Mkt cap
- 1.92M
- Vol
- 4.61K
- Avg vol
- 1.27M
- EPS
- -47.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.17
- High
- 1.25
- Forward P/E
- -1.69
- Beta
- 0.38
- Short ratio
- 0.43
- Inst. own
- 9.33%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.64
- 200-d avg
- 8.21
- 1y target
- 33.00
1D chart
Chart tools
Chart is warming up
The one-day price history for PPBT has not been loaded yet. Try again in a moment.
Altman Z-Score
-22.13 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
P/E -1.2×
P/S 0.0×
P/B 3.2×
P/FCF -5.7×
EV/EBITDA -0.9×
EV/Sales 0.0×
FCF Yield -17.6%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -271.6%
ROIC -272.9%
ROA -150.2%
Revenue 0.0%
Operating Income -149.5%
EPS (diluted) -24.4%
Free Cash Flow 61.4%
Current Ratio 1.3×
Quick Ratio 1.3×
Debt / Equity 0.0×
Net Debt / EBITDA 0.3×
Interest Coverage -704×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31